Fri, Jul 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Diva Synergy Fund gains over 27% in 2010; Bernheim, Dreyfus anticipates further strong year for M&A (and for the Fund)

Friday, January 07, 2011
Opalesque Industry Update - Paris-based M&A investment manager, Bernheim, Dreyfus, has announced continuing strong performance for its flagship Diva Synergy Enhanced Fund through 2010. In the 12 month period, the Fund’s dollar class gained +27.35% net and the euro class +27.91%.

The strength of Diva Synergy reflects, to some extent, the growth in global mergers and acquisitions. According to Bernheim, Dreyfus’s January research letter, “the value of worldwide M&A totalled $2.4 trillion during the full year 2010, a 23% increase from comparable 2009 levels and the strongest full year period for M&A since 2008.

Looking forward, the letter anticipates “deal activity will remain solid, focused around strategic deal-making. Resurgent leveraged buyout activity is supported by favourable conditions in the credit markets.”

Bernheim, Dreyfus highlights three sectors where research predicts 2011 M&A will be particular buoyant:

IT. There were more than 70 tech/IT acquisitions – lathe and small – by the major industry leaders in 2010, compared to 33 in 2009 and 55 in 2008. The tech sector is certainly recovering from the recession and not shying away from deals.

Financial. With new government regulations on the books or being written in response to Dodd-Franks, many of the big banks will be looking to unload certain riskier business units, like those tied to derivatives and hedge funds. Other companies will be eager to jump in and enter the lucrative areas of financing and banking.

Healthcare. Big pharmaceutical companies like Eli Lilly, Pfizer and Merck, along with biotech firms and those in the health care services sectors will all be on the prowl. Increasing demand from an ageing population, health care legislation and expiring patents creates the need to buy smaller biotech firms with new drug discoveries.

(press release)

Bernheim, Dreyfus & Co

Paris-based Bernheim, Dreyfus & Co was founded in 2006 as an alternative investment firm focusing on M&A-related strategies, managing an event driven hedge fund – Diva Synergy.

Diva Synergy is managed by Amit Shabi and Lionel Melka. Lionel has 10 years’ of experience as an M&A advisor for blue chip clients in prestigious banks as Lazards, Calyon and Rothschilds. He has been involved in more than 20 major transactions totalling more than $50 billion.

Amit has long experience in asset management and in sales of OTC hedging strategies in companies like Rothschild and Man Group...Corporate website: Source
KM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds panic over Greece[more]

    Komfie Manalo, Opalesque Asia: Some investors are in panic mode as Greek Prime Minister Alexis Tsipras announced Sunday night that the banks and the stock market would be closed Monday, said

 

banner